CN106290624B - 一种分离测定药物制剂中防腐杀菌剂和抗氧化剂的方法 - Google Patents
一种分离测定药物制剂中防腐杀菌剂和抗氧化剂的方法 Download PDFInfo
- Publication number
- CN106290624B CN106290624B CN201610615328.3A CN201610615328A CN106290624B CN 106290624 B CN106290624 B CN 106290624B CN 201610615328 A CN201610615328 A CN 201610615328A CN 106290624 B CN106290624 B CN 106290624B
- Authority
- CN
- China
- Prior art keywords
- mobile phase
- pharmaceutical preparation
- sample
- anticorrosion
- gelling agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 48
- 239000000825 pharmaceutical preparation Substances 0.000 title claims abstract description 30
- 239000003963 antioxidant agent Substances 0.000 title claims abstract description 28
- 230000003078 antioxidant effect Effects 0.000 title claims abstract description 28
- 239000003899 bactericide agent Substances 0.000 title claims abstract description 27
- 238000000926 separation method Methods 0.000 title claims abstract description 22
- 239000007788 liquid Substances 0.000 claims abstract description 17
- 238000001514 detection method Methods 0.000 claims abstract description 13
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 claims description 63
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical group COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 54
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims description 48
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims description 48
- 239000003349 gelling agent Substances 0.000 claims description 45
- RLSSMJSEOOYNOY-UHFFFAOYSA-N m-cresol Chemical group CC1=CC=CC(O)=C1 RLSSMJSEOOYNOY-UHFFFAOYSA-N 0.000 claims description 45
- 229940100630 metacresol Drugs 0.000 claims description 45
- 239000003085 diluting agent Substances 0.000 claims description 42
- 239000000523 sample Substances 0.000 claims description 37
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 claims description 32
- 229960003415 propylparaben Drugs 0.000 claims description 32
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 claims description 31
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 30
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 27
- 239000012488 sample solution Substances 0.000 claims description 27
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 26
- 239000007864 aqueous solution Substances 0.000 claims description 20
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 20
- 238000002360 preparation method Methods 0.000 claims description 18
- 239000002674 ointment Substances 0.000 claims description 15
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 claims description 13
- 239000000377 silicon dioxide Substances 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 11
- 238000005070 sampling Methods 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 10
- 235000019253 formic acid Nutrition 0.000 claims description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 8
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- 108010081589 Becaplermin Proteins 0.000 claims description 4
- 102100040990 Platelet-derived growth factor subunit B Human genes 0.000 claims description 4
- HYNPZTKLUNHGPM-KKERQHFVSA-N becaplermin Chemical group CC[C@H](C)[C@@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N3CCC[C@H]3C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]5CCCN5C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]6CCCN6C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]7CCCN7C(=O)[C@H](Cc8c[nH]c9c8cccc9)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)N HYNPZTKLUNHGPM-KKERQHFVSA-N 0.000 claims description 4
- 229960004787 becaplermin Drugs 0.000 claims description 4
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 claims description 3
- 229930105110 Cyclosporin A Natural products 0.000 claims description 3
- 239000003889 eye drop Substances 0.000 claims description 3
- 229940012356 eye drops Drugs 0.000 claims description 3
- 239000003960 organic solvent Substances 0.000 claims description 3
- 239000003973 paint Substances 0.000 claims description 3
- 239000007789 gas Substances 0.000 claims description 2
- 239000003595 mist Substances 0.000 claims description 2
- 238000003556 assay Methods 0.000 abstract 1
- 230000003647 oxidation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
- 230000003449 preventive effect Effects 0.000 abstract 1
- 239000012071 phase Substances 0.000 description 46
- 239000000243 solution Substances 0.000 description 31
- 239000013558 reference substance Substances 0.000 description 28
- 238000012360 testing method Methods 0.000 description 17
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 10
- 239000003814 drug Substances 0.000 description 10
- UDEWPOVQBGFNGE-UHFFFAOYSA-N propyl benzoate Chemical compound CCCOC(=O)C1=CC=CC=C1 UDEWPOVQBGFNGE-UHFFFAOYSA-N 0.000 description 8
- 239000012085 test solution Substances 0.000 description 8
- 229940079593 drug Drugs 0.000 description 7
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 6
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 6
- 238000010812 external standard method Methods 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- 238000002604 ultrasonography Methods 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- 239000012490 blank solution Substances 0.000 description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
- 229960002216 methylparaben Drugs 0.000 description 5
- 229960003742 phenol Drugs 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 238000004811 liquid chromatography Methods 0.000 description 4
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 3
- 239000005711 Benzoic acid Substances 0.000 description 3
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 3
- 235000010233 benzoic acid Nutrition 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 229940126680 traditional chinese medicines Drugs 0.000 description 3
- UHOPWFKONJYLCF-UHFFFAOYSA-N 2-(2-sulfanylethyl)isoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(CCS)C(=O)C2=C1 UHOPWFKONJYLCF-UHFFFAOYSA-N 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 150000001896 cresols Chemical class 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- GHEZNRQAMLNCNT-UHFFFAOYSA-N C(=O)OCCC.OC1=CC=CC=C1 Chemical compound C(=O)OCCC.OC1=CC=CC=C1 GHEZNRQAMLNCNT-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000003260 anti-sepsis Effects 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- -1 hydroxyl Propyl Chemical group 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229940095102 methyl benzoate Drugs 0.000 description 1
- OLXYLDUSSBULGU-UHFFFAOYSA-N methyl pyridine-4-carboxylate Chemical compound COC(=O)C1=CC=NC=C1 OLXYLDUSSBULGU-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000008252 pharmaceutical gel Substances 0.000 description 1
- FOWDZVNRQHPXDO-UHFFFAOYSA-N propyl hydrogen carbonate Chemical compound CCCOC(O)=O FOWDZVNRQHPXDO-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Sampling And Sample Adjustment (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
时间(分钟) | 流动相A%(体积百分比) | 流动相B%(体积百分比) |
0 | 45 | 55 |
5 | 45 | 55 |
8 | 80 | 10 |
15 | 80 | 10 |
17 | 45 | 55 |
20 | 45 | 55。 |
时间(分钟) | 流动相A(体积百分比) | 流动相B%(体积百分比) |
0 | 45% | 55% |
5 | 45% | 55% |
8 | 80% | 10% |
15 | 80% | 10% |
17 | 45% | 55% |
20 | 45% | 55%。 |
时间(分钟) | 流动相A%(体积百分比) | 流动相B%(体积百分比) |
0 | 45 | 55 |
5 | 45 | 55 |
8 | 80 | 10 |
15 | 80 | 10 |
17 | 45 | 55 |
20 | 45 | 55。 |
时间(分钟) | 流动相A(体积百分比) | 流动相B%(体积百分比) |
0 | 45% | 55% |
5 | 45% | 55% |
8 | 80% | 10% |
15 | 80% | 10% |
17 | 45% | 55% |
20 | 45% | 55%。 |
时间(分钟) | 流动相A%(体积百分比) | 流动相B%(体积百分比) |
0 | 45 | 55 |
5 | 45 | 55 |
8 | 80 | 10 |
15 | 80 | 10 |
17 | 45 | 55 |
20 | 45 | 55 |
时间(分钟) | 流动相A%(体积百分比) | 流动相B%(体积百分比) |
0 | 45 | 55 |
5 | 45 | 55 |
8 | 80 | 10 |
15 | 80 | 10 |
17 | 45 | 55 |
20 | 45 | 55 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610615328.3A CN106290624B (zh) | 2016-07-29 | 2016-07-29 | 一种分离测定药物制剂中防腐杀菌剂和抗氧化剂的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610615328.3A CN106290624B (zh) | 2016-07-29 | 2016-07-29 | 一种分离测定药物制剂中防腐杀菌剂和抗氧化剂的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106290624A CN106290624A (zh) | 2017-01-04 |
CN106290624B true CN106290624B (zh) | 2019-07-09 |
Family
ID=57663727
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610615328.3A Active CN106290624B (zh) | 2016-07-29 | 2016-07-29 | 一种分离测定药物制剂中防腐杀菌剂和抗氧化剂的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106290624B (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103063764A (zh) * | 2012-12-21 | 2013-04-24 | 林维宣 | 一种化妆品中多种防腐剂残留量的检测方法 |
CN103076407A (zh) * | 2012-12-26 | 2013-05-01 | 通标标准技术服务有限公司 | 一种食品中防腐剂和抗氧化剂的快速检测方法 |
CN103383382A (zh) * | 2013-06-28 | 2013-11-06 | 上海相宜本草化妆品股份有限公司 | 用于检测化妆品中尼泊金酯类及其复配防腐剂的方法 |
CN104374843A (zh) * | 2014-11-11 | 2015-02-25 | 广东东阳光药业有限公司 | 一种同时测定凝胶剂中对羟基苯甲酸甲酯、对羟基苯甲酸丙酯和二丁基羟基甲苯的方法 |
CN105527355A (zh) * | 2015-12-08 | 2016-04-27 | 云南中烟工业有限责任公司 | 一种水基胶中防腐剂和抗氧化剂残留量的共检出测定方法 |
-
2016
- 2016-07-29 CN CN201610615328.3A patent/CN106290624B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103063764A (zh) * | 2012-12-21 | 2013-04-24 | 林维宣 | 一种化妆品中多种防腐剂残留量的检测方法 |
CN103076407A (zh) * | 2012-12-26 | 2013-05-01 | 通标标准技术服务有限公司 | 一种食品中防腐剂和抗氧化剂的快速检测方法 |
CN103383382A (zh) * | 2013-06-28 | 2013-11-06 | 上海相宜本草化妆品股份有限公司 | 用于检测化妆品中尼泊金酯类及其复配防腐剂的方法 |
CN104374843A (zh) * | 2014-11-11 | 2015-02-25 | 广东东阳光药业有限公司 | 一种同时测定凝胶剂中对羟基苯甲酸甲酯、对羟基苯甲酸丙酯和二丁基羟基甲苯的方法 |
CN105527355A (zh) * | 2015-12-08 | 2016-04-27 | 云南中烟工业有限责任公司 | 一种水基胶中防腐剂和抗氧化剂残留量的共检出测定方法 |
Non-Patent Citations (4)
Title |
---|
姜玲玲 等.高效液相色谱法同时测定食品中19种防腐杀菌剂.《食品工业》.2014,第35卷(第12期), |
张菁 等.HPLC法同时测定盐酸林可霉素滴眼液中有关物质和防腐剂含量.《中国药房》.2013,第24卷(第45期), |
曾立华 等.高效液相色谱测定复方硝酸益康唑乳膏中尼泊金酯的含量.《湖南师范大学学报(医学版)》.2008,第5卷(第4期), |
郭江红 等.HPLC法同时测定氯霉素滴眼液中有关物质和尼泊金酯类防腐剂.《药物分析杂志》.2009,第29卷(第12期), |
Also Published As
Publication number | Publication date |
---|---|
CN106290624A (zh) | 2017-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104374843B (zh) | 一种同时测定凝胶剂中对羟基苯甲酸甲酯、对羟基苯甲酸丙酯和二丁基羟基甲苯的方法 | |
CN106841413A (zh) | 一种替格瑞洛对映异构体、非对映异构体的分离检测方法 | |
CN104749269A (zh) | 一种利用hplc测定阿格列汀原料药及制剂中对映异构体杂质的方法 | |
CN105699524A (zh) | 一种替格瑞洛中异构体杂质含量的检测方法 | |
CN106841457B (zh) | 一种动物源性食品中安眠酮和地西泮残留量的测定方法 | |
CN101738444A (zh) | 三聚氰胺的检测方法 | |
CN103776930A (zh) | 清凉油含量测定方法 | |
CN105510482A (zh) | 一种替格瑞洛原料中异构体杂质含量的检测方法 | |
CN109239228B (zh) | 一种蜂胶及以蜂胶为原料的保健食品中氯霉素的检测方法 | |
CN107957467B (zh) | 一种分离测定药物制剂中溶血磷脂酰胆碱的方法 | |
CN110514775A (zh) | 一种单宁酸的高效液相色谱分析方法 | |
CN102305831B (zh) | 脑蛋白水解物片的检测方法 | |
CN106290624B (zh) | 一种分离测定药物制剂中防腐杀菌剂和抗氧化剂的方法 | |
CN112213424A (zh) | 一种阿托伐他汀钙中间体中共存杂质同时测定方法 | |
CN106290680B (zh) | 头孢美唑酸的中间体s-氰甲基异硫脲的分析方法 | |
CN114994205B (zh) | 地拉罗司颗粒剂中相关杂质的检测方法 | |
CN111060613A (zh) | 化妆品中防腐剂的分析检测方法 | |
CN114414680B (zh) | 一种多种小分子酸酐中有关物质的测定方法 | |
CN105548393A (zh) | 一种检测阿普斯特原料中杂质含量的方法 | |
CN104880517A (zh) | 一种中药制剂中痕量成分含量的测定方法 | |
CN116265937A (zh) | 一种磷酸奥司他韦有关杂质的检测方法及应用 | |
CN114594168A (zh) | 一种吲哚布芬杂质的检测方法 | |
CN104569260A (zh) | 一种检测粘菌素甲烷磺酸钠中甲醛残留量的方法 | |
CN112129847A (zh) | 一种d-对羟基苯甘氨酸甲酯含量的检测方法 | |
CN111912922A (zh) | 测定农药中丙环唑和咪鲜胺含量的高效液相色谱分析方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190814 Address after: 201908 Shanghai city Baoshan District Luo Road No. 50 -1 Co-patentee after: Jiangsu Jingze Biomedical Co.,Ltd. Patentee after: SHANGHAI JINGZE BIOLOGICAL TECHNOLOGY CO.,LTD. Address before: 201908 Shanghai city Baoshan District Luo Road No. 50 -1 Patentee before: SHANGHAI JINGZE BIOLOGICAL TECHNOLOGY CO.,LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: No.50-1, Luoxin Road, Baoshan District, Shanghai, 201908 Patentee after: SHANGHAI JINGZE BIOLOGICAL TECHNOLOGY CO.,LTD. Patentee after: Jingze biomedical (Hefei) Co.,Ltd. Address before: No.50-1, Luoxin Road, Baoshan District, Shanghai, 201908 Patentee before: SHANGHAI JINGZE BIOLOGICAL TECHNOLOGY CO.,LTD. Patentee before: Jiangsu Jingze Biomedical Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: No.50-1, Luoxin Road, Baoshan District, Shanghai, 201908 Patentee after: SHANGHAI JINGZE BIOLOGICAL TECHNOLOGY CO.,LTD. Patentee after: Jingze Biomedical (Hefei) Co.,Ltd. Address before: No.50-1, Luoxin Road, Baoshan District, Shanghai, 201908 Patentee before: SHANGHAI JINGZE BIOLOGICAL TECHNOLOGY CO.,LTD. Patentee before: Jingze biomedical (Hefei) Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231124 Address after: No.50-1, Luoxin Road, Baoshan District, Shanghai, 201908 Patentee after: SHANGHAI JINGZE BIOLOGICAL TECHNOLOGY CO.,LTD. Patentee after: Jingze Biomedical (Hefei) Co.,Ltd. Patentee after: Suzhou Jingze Biopharmaceutical Co.,Ltd. Address before: No.50-1, Luoxin Road, Baoshan District, Shanghai, 201908 Patentee before: SHANGHAI JINGZE BIOLOGICAL TECHNOLOGY CO.,LTD. Patentee before: Jingze Biomedical (Hefei) Co.,Ltd. |
|
TR01 | Transfer of patent right |